Quay lại
Giá Antengene Corporation Limited (06996.HK)
Biểu đồ giá cổ phiếu 06996.HK
ANTENGENE-B (06996.HK)
Antengene Corporation Limited
HK$3.6
-1.09%
$-0.04
Thị trường chính thức: Jan 21, 16:03:12 HKT
Thống kê chính
Giá đóng cửa trước
$3.7
Giá mở cửa
$3.64
Phạm vi ngày
$3.54 - $3.68
Phạm vi 52 tuần
$0.69 - $8.16
Khối lượng
2.5M
Khối lượng trung bình
2.4M
EPS (TTM)
-0.40
Tỷ suất cổ tức
--
Vốn hóa thị trường
$2.1B
ANTENGENE-B là gì?
Antengene Corp. Ltd. operates as a clinical-stage Asia-Pacific biopharmaceutical company. The company is headquartered in Shanghai, Shanghai and currently employs 152 full-time employees. The company went IPO on 2020-11-20. The firm is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The firm's products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The firm mainly conducts its business in Asia-Pacific.
Đặc điểm
Chiến lược giao dịch
Tài nguyên
© 2025 Finture Development Limited. All rights reserved
